Stock VRCA VERRICA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Verrica Pharmaceuticals Inc.

Equities

VRCA

US92511W1080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
8.51 USD +2.16% Intraday chart for Verrica Pharmaceuticals Inc. -0.58% +16.26%
May. 15 Verrica Pharmaceuticals Amends Licensing Agreement With Torii Pharmaceutical for Phase 3 Trial of Ycanth MT
May. 15 Verrica Pharmaceuticals Inc. Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study Ycanth for the Treatment of Common Warts CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERRICA PHARMACEUTICALS INC. Stock Verrica Pharmaceuticals Inc.
 361M - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
 318B
ABBVIE INC. Stock AbbVie Inc.
 285B
  1. Stock Market
  2. Equities
  3. VRCA Stock
  4. Charts Verrica Pharmaceuticals Inc.
  5. Sector Chart